DexCom Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +107.6% | +14.7% | +63.7% | +33.9% | +155.3% | +51.2% | -7.0% | +51.3% | +11.8% | +32.2% | +45.6% | |
| – | +28.6% | +38.9% | +7.3% | +80.7% | +67.4% | +37.8% | +52.0% | +52.8% | +19.3% | +17.0% | +15.7% | |
| – | +65.4% | +34.0% | -4.2% | -4.0% | +0.8% | +16.3% | -5.0% | +11.6% | +19.2% | +13.0% | -6.3% | |
| – | +65.7% | +35.9% | +0.9% | -38.1% | +54.4% | -159.0% | – | -39.8% | – | – | – | |
| – | – | – | – | -1,673.1% | – | -441.0% | – | – | -88.4% | +3,300.0% | -5.0% | |
| – | +105.6% | +67.3% | +18.5% | +1.7% | +168.3% | +10.6% | +95.6% | -6.3% | -35.1% | +51.6% | +1.3% | |
| – | +206.5% | +8.5% | +158.3% | -3.2% | +626.2% | +0.3% | -78.8% | +141.3% | -2.7% | -59.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -20.4% | -45.5% | -2.9% | -1,090.1% | – | +28.6% | +32.7% | -2,847.3% | +23.5% | +8.9% | -33.3% | |
| – | +4.5% | +0.0% | – | +115.1% | +8.3% | +31.2% | -100.0% | – | – | -100.0% | – | |
| – | -22.9% | -51.8% | +4,827.2% | +78.0% | -98.5% | +8,424.3% | -98.9% | -5,412.5% | -42.3% | +130.6% | +129.5% | |
| – | -50.0% | -41.3% | +4,031.0% | +100.5% | -199.3% | – | -36.7% | -274.3% | – | – | +683.4% | |
| – | +112.2% | -96.8% | +5,100.0% | +115.8% | +139.8% | +105.7% | -80.7% | +471.7% | +68.0% | +23.2% | +70.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.